The are no investigational devices being tested for this study. The ClearSight/Nexfin System is an FDA approved device that is widely used in the perioperative setting. To restate, this study is similar assessing its utility in the outpatient heart failure clinics. All devices used for this study will be cleared by biomedical engineering prior to use as per hospital equipment protocol.